Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-01-31

Clinical Trial Update: Minimum Oxytocin Dose for Cesarean During Labor: Adaptative Clinical Trial [Phase 3]

View source ↗

Summary

An adaptive Phase 3 clinical trial update evaluating the minimum oxytocin dose needed for cesarean delivery during labor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxytocin (Oxytocin)

Snippet

Sponsor: Brasilia University Hospital | Conditions: Cesarean Section During Labor | Phase 3 | Status: UNKNOWN